USPTO serial 98313412
Serial No. 98313412
Reviewed by CopyMark Law Group
Status 732Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- CHUNG, ABBIE
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with Serial No. 98313412?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,246*
Plus Government fees of $600
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Scotts Valley, CA, US
Scotts Valley, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mark I. Koffsky
Mark I. Koffsky Koffsky Schwalb LLC500 Seventh Avenue, 8th FloorNew York, NY 10018United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable software as a Medical Device (SaMD) for treating neuropsychiatric disorders, namely, depression, anxiety disorders, OCD, substance use disorders, PTSD, cognitive disorders, and sensorimotor deficits; Downloadable computer software for controlling and managing patient medical information; Downloadable medical software as a medical device (SaMD) for treatment of neuropsychiatric disorders, namely, depression, anxiety disorders, OCD, substance use disorders, PTSD, cognitive disorders, and sensorimotor deficits; Computer hardware and recorded software sold as a unit for use with electrocorticographic stimulation devices, for receiving, processing, transmitting and displaying data; Interfaces for computers, namely, intracalvarial neural interface featuring a power supply pod device providing wireless power to implants allowing patients to interface with computer hardware via brain activity; Wearable wireless chargers in the form of a device providing wireless power to implants; Downloadable software for connecting, operating, and managing networked hardware devices, namely, intracalvarial neural implants, a device providing wireless power to implants, computer hardware, phones, laptops, desktop computers, tablet computers, and wearable devices being smartwatches, smart rings, headsets in the internet of things (IoT); Microcontrollers for internet of things (IoT) enabled devices; Downloadable computer software for operating therapeutic, diagnostic and rehabilitation medical systems, namely, computer software to measure biometric data for diagnosing and treating neuropsychiatric disorders, namely depression, anxiety disorders, OCD, substance use disorders, PTSD, addiction, cognitive disorders, sensorimotor deficits; Downloadable computer software in the field of data management for processing medical data, patient data, and demographic data, namely, data acquisition, data visualization, automatic data analysis, statistic data analysis, automated report generation, comparative data analysis, data export/import, data searching, data synchronization tools, using artificial intelligence | ACTIVE | — |
| 010 | Implants consisting of artificial materials; Wearable monitors used to measure biometric data for medical use; Medical devices for use in treating or diagnosing neuropsychiatric disorders, namely, depression, anxiety disorders, OCD, substance use disorders, PTSD, cognitive disorders, and sensorimotor deficits, with integrated recorded operating system software, sold as a unit; Surgical and medical apparatus and instruments, namely, electrocorticographic stimulation apparatus for the treatment of neuropsychiatric disorders including depression, anxiety disorders, OCD, substance use disorders, PTSD, cognitive disorders, and sensorimotor deficits; Non-invasive electronic neuromodulator device for medical use, namely, for the treatment of neuropsychiatric disorders including depression, anxiety disorders, OCD, substance use disorders, PTSD, cognitive disorders, and sensorimotor deficits, all using artificial intelligence; Surgical and medical apparatus and instruments, namely, electrotherapy stimulation apparatus comprising electrodes for the stimulation of nerves and brain tissue using an electric field, for medical purposes; Electrocorticographic stimulation devices for physical therapy and medical therapy purposes | ACTIVE | — |
| 042 | Medical research; Medical and scientific research in the field of neuropsychiatric disorders including depression, anxiety disorders, OCD, substance use disorders, PTSD, cognitive disorders, and sensorimotor deficits, brain wave sensing and stimulation, brain/computer interface, all using artificial intelligence; Compiling data for research purposes in the field of medical science and medical consultancy; Providing temporary use of non-downloadable computer software in the field of data management for processing medical data, patient data, and demographic data, namely, data acquisition, data visualization, automatic data analysis, statistic data analysis, automated report generation, comparative data analysis, data export/import, data searching, data synchronization tools, using artificial intelligence | ACTIVE | — |
| 044 | Medical care; Provision of medical services by health care professionals via the internet or telecommunication networks; Remote monitoring of medical data for medical diagnosis and treatment; Providing medical information in the fields of neuropsychiatric disorders including depression, anxiety disorders, OCD, substance use disorders, PTSD, cognitive disorders, and sensorimotor deficits, brain wave stimulation, and brain-computer interface; Medical diagnostic testing, monitoring and reporting services using artificial intelligence; Medical treatment of neuropsychiatric disorders including depression, anxiety disorders, OCD, substance use disorders, PTSD, cognitive disorders, and sensorimotor deficits; Surgical implantation of subcutaneous microchips into humans; Medical services for treatment of neuropsychiatric disorders, including depression, anxiety disorders, OCD, substance use disorders, PTSD, cognitive disorders, and sensorimotor deficits | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 18, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 18, 2026 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Aug 17, 2026 | EXT3 | SOU EXTENSION 3 FILED | — |
| Aug 17, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 16, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 16, 2026 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Mar 16, 2026 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Mar 1, 2026 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Mar 1, 2026 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Mar 1, 2026 | PETG | PETITION TO REVIVE-GRANTED | — |
| Mar 1, 2026 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Feb 18, 2026 | EXT2 | SOU EXTENSION 2 FILED | — |
| Aug 17, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 17, 2025 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 16, 2025 | EXT1 | SOU EXTENSION 1 FILED | — |
| Aug 16, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 18, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 24, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 24, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 18, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 2, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 2, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 2, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 2, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 2, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 24, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 24, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 24, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Nov 12, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Nov 12, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 12, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 14, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 13, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 13, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 16, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 16, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 16, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 12, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 18, 2024 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Mar 18, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 13, 2023 | NWAP | NEW APPLICATION ENTERED | — |